PMCTPharmaCountry
    Inicio
ARCALIS, Inc. logo
ARCALIS, Inc.

ARCALIS, Inc.

Fabricante por Contrato (CMO) · Clasificación ATC (Anatómica, Terapéutica, Química)Flag of JPJapan
1.3K
27
17
3.5(72)

Sobre la Empresa

  • Nombre legal: ARCALIS, Inc.
  • País de registro: Japan
  • Dirección: 226-39, Wakashiba,,, Kashiwa Shi
  • Número de empleados: 100 - 249
Descripción:

A CDMO specializing in mRNA medicines and vaccines, founded by Axcelead (Japan's first drug discovery platform) and Arcturus Therapeutics (a US mRNA company). In 2023, ARCALIS opened a GMP mRNA drug substance facility in Japan, and in 2024 achieved the world's first commercial production of a self-amplifying mRNA COVID-19 vaccine, supporting clients from early research through commercial production across rare diseases, oncology, regenerative medicine and genome editing.

Actividades Comerciales

Clasificación ATC (Anatómica, Terapéutica, Química)

Fabricante por Contrato (CMO)
Productos/Servicios Clave

Nuestros Productos & Servicios

Sell · Contract & Outsourcing Services
ARCALIS, Inc. sell "Non-GMP mRNA Development & CMC Services"
ARCALIS, Inc.
ARCALIS, Inc.
Flag of JP Japan

ARCALIS, Inc. sell "Non-GMP mRNA Development & CMC Services"

Non-GMP mRNA Development & CMC Services

Service Provider: ARCALIS, Inc., Japan

Ver detalles
Sell · Contract & Outsourcing Services
ARCALIS, Inc. sell "GMP Manufacturing Services for mRNA and LNP"
ARCALIS, Inc.
ARCALIS, Inc.
Flag of JP Japan

ARCALIS, Inc. sell "GMP Manufacturing Services for mRNA and LNP"

GMP Manufacturing Services for mRNA and LNP

Service Provider: ARCALIS, Inc., Japan

Ver detalles

Certifications

GMP

Filtros:
Ordenar por:

    No hay comentarios disponibles.